2002至2014年丹麦外周动脉疾病患者血管重建后重大截肢趋势
该研究基于丹麦血管登记与国家医疗行政数据库,纳入2002至2014年25982例首次因外周动脉疾病行血管重建的患者,其中2883例(11.1%)发生重大截肢。截肢风险与血管病变严重程度高度相关,溃疡/坏疽是最强预测因子(HR 8.06,CI 7.11-9.13,p < .001)。地理区域间血管治疗强度存在差异,但未能解释各辖区重大截肢风险的差异。
要点
- 25982例首次血管重建患者中2883例(11.1%)发生重大截肢。
- 溃疡/坏疽是截肢最强预测因子,HR 8.06(CI 7.11-9.13,p < .001)。
- 首次血管重建至截肢中位时间4.66个月,63.1%的截肢发生在术后1年内。
核心结论
- 尽管更多外周动脉疾病患者接受血管重建,仍有十分之一最终发生下肢重大截肢。
- 截肢风险与血管重建时血管病变严重程度高度相关,溃疡/坏疽为最强预测因子。
- 地理区域间血管治疗强度存在差异,但未能解释各辖区重大截肢风险的差异。
研究设计与样本
- 基于丹麦血管登记与国家人口医疗及行政数据库的全国性人群研究,纳入2002至2014年因外周动脉疾病首次行血管重建(腔内、开放及杂交手术)的患者。
- 采用Cox比例风险回归评估重大截肢与各相关因素的关系。
主要发现
- 2002至2014年共行25982例首次血管重建,2883例(11.1%)发生重大截肢。
- 血管重建总数增至2010年后略有下降。
- 以腔内血管重建作为首次重建的比例呈上升趋势:2002年36.6% vs 2014年59.0%(p < .001)。
- 首次血管重建至重大截肢的中位时间为4.66个月(范围0.03-146.88个月),63.1%的重大截肢发生在血管重建后1年内;研究期间1年内截肢数无变化(p = .251)。
- 重大截肢最强预测因子为血管重建时溃疡/坏疽(HR 8.06,CI 7.11-9.13,p < .001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Contemporary information on major amputations after revascularisation in Denmark is sparse. This population based national study aimed to determine outcomes following revascularisation for PAD and to identify predictors of major amputation after revascularisation, including geographical variation. METHODS: Data on patients with PAD undergoing revascularisation (endovascular, open, and hybrid procedures) from 2002 to 2014 were obtained from the Danish Vascular Registry and linked with information from population based healthcare and administrative databases. Cox proportional hazards regression was used to assess the relationship between major amputation and the various associated factors. RESULTS: In all 25,982 first time vascular reconstructions for PAD were performed between 2002 and 2014 and major amputations were performed in 2883 (11.1%) of the patients. The total number of revascularisations increased up to 2010 and thereafter numbers decreased slightly. A trend towards endovascular revascularisation as first time revascularisation was seen (36.6% in 2002 vs. 59.0% in 2014, p < .001). Median time from first revascularisation to major amputation was 4.66 months (range 0.03-146.88 months), and 63.1% of major amputations were performed within one year following revascularisation. No change in the number of amputations performed within one year after revascularisation was found during the study (p = .251). The strongest predictor for major amputations was ulcers/gangrene (HR 8.06, CI 7.11-9.13, p < .001) at the time of revascularisation. Geographic variation for intensity of revascularisation was observed and geographic differences in amputation free survival for patients with intermittent claudication and ulcers/gangrene were found. CONCLUSION: Although more patients with PAD undergo revascularisation, one in 10 still ends up with a major amputation of the lower limb. The risk of amputation was highly associated with the severity of the vascular disease at the time of revascularisation, with ulcers/gangrene as the strongest predictor. Geographic differences in vascular treatment intensity were found, but these failed to explain the differences in risk of major amputation after revascularisation across catchment areas.
引用
- Londero LS, Høgh A, Houlind K, et al. Danish Trends in Major Amputation After Vascular Reconstruction in Patients With Peripheral Arterial Disease 2002-2014. Eur J Vasc Endovasc Surg. 2018. PMID: 30293885. doi:10.1016/j.ejvs.2018.08.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。